The pharmacokinetics of nimodipine, intravenous and orally, in patients with subarachnoidal hemorrhage admitted in the intensive care.

Completed

• Conditions: subarachnoidal hemorrhagetreatment in intensive care

• Registration Number: NL-OMON21573
• Lead Sponsor: none

Brief Summary

/A

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 28 February 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 12

Inclusion Criteria

1. All patients admitted on the ICU with subarachnoidal hemorrhage (SAB), treated according to our SAB-protocol;

2. Adults aged 18 - 70 years old.

Exclusion Criteria

1. Pregnancy;

2. Expected mortality < 24 hours;

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
1. Pharmacokinetics of nimodipine in this specific group of patients;<br /><br>2. Variability of bio-availability of orally administred nimodipine.